Top-News

Jazz Pharmaceuticals Aktie News

Aktie
WKN:  A1JS1K ISIN:  IE00B4Q5ZN47 US-Symbol:  JAZZ Branche:  Biotechnologie Land:  Irland
169,70 $
+2,79 $
+1,67%
145,74 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
7,36 Mrd. €
Streubesitz
-
KGV
-
neu: Nachhaltigkeits-Score
37 %
Index-Zuordnung
-
Weiter aufwärts? Long handeln - Jetzt mit Hebel 5,88: JZ02F8
Werbung

Jazz Pharmaceuticals News

22.04.25 - PR Newswire
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025 PR Newswire
22.04.25 - PR Newswire
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025 PR Newswire
21.04.25 - PR Newswire
Jazz Pharmaceuticals Completes Acquisition of Chimerix
Jazz Pharmaceuticals Completes Acquisition of Chimerix PR Newswire
21.04.25 - PR Newswire
Jazz Pharmaceuticals Completes Acquisition of Chimerix
Jazz Pharmaceuticals Completes Acquisition of Chimerix PR Newswire
26.03.25 - PR Newswire
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference PR Newswire
26.03.25 - PR Newswire
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference PR Newswire
19.03.25 - PR Newswire
Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting
Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® ...
10.03.25 - LYNX Analysen
Jazz Pharmaceuticals mit Rückenwind
Das irische Pharmaunternehmen trotzt der allgemein schwachen Entwicklung der Wall Street und zeigt seit geraumer Zeit Relative Stärke gegenüber dem Gesamtmarkt. Jetzt ...
05.03.25 - PR Newswire
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio PR Newswire
05.03.25 - PR Newswire
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio PR Newswire
25.02.25 - PR Newswire
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance PR Newswire
25.02.25 - PR Newswire
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance PR Newswire
20.02.25 - PR Newswire
Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference
Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference PR Newswire
20.02.25 - PR Newswire
Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference
Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference PR Newswire
11.02.25 - PR Newswire
Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025
Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025 PR Newswire
17.12.24 - PR Newswire
Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire
17.12.24 - PR Newswire
Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire
16.12.24 - PR Newswire
Jazz Pharmaceuticals Announces CEO Succession Plan
Jazz Pharmaceuticals Announces CEO Succession Plan PR Newswire
16.12.24 - PR Newswire
Jazz Pharmaceuticals Announces CEO Succession Plan
Jazz Pharmaceuticals Announces CEO Succession Plan PR Newswire
06.12.24 - PR Newswire
Jazz Pharmaceuticals to Showcase New Real-World Evidence Reinforcing Epidiolex® (cannabidiol) Benefits and Broad-Spectrum Efficacy in Treatment-Resistant Epilepsies at the American Epilepsy Society 2024 Annual Meeting
Jazz Pharmaceuticals to Showcase New Real-​World Evidence Reinforcing Epidiolex® (cannabidiol) Benefits and Broad-​Spectrum Efficacy in Treatment-​Resistant Epilepsies at the ...

Newssuche

Videos

newspaper
05.12.25 +1,73%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »